Via Top Health News -- ScienceDaily
The substitution of a single amino acid in a metabolic enzyme can be the cause of various types of cancer. Scientists have now been able to develop a candidate for an agent that is intended to specifically block the altered enzyme. First studies in mice have demonstrated preclinical effects of this investigational compound.
View original post here: